Bio Imaging Technologies Inc - Amended Statement of Ownership (SC 13G/A)
June 19 2008 - 5:05PM
Edgar (US Regulatory)
|
OMB
APPROVAL
|
|
OMB
Number: 3235-0145
|
|
Expires: February
28, 2009
|
|
Estimated
average burden
Hours
per
response 10.4
|
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
13G/A
Under
the Securities Exchange Act of 1934
(Amendment
No. 2)*
Bio-Imaging
Technologies, Inc.
-------------------------------------------------------------------------------
(Name of
Issuer)
Common
Stock
-------------------------------------------------------------------------------
(Title of
Class of Securities)
09056N103
----------------------------------------
(CUSIP
Number)
June 9,
2008
-------------------------------------------------------------------------------
(Date of
Event Which Requires Filing of this Statement)
Check the
appropriate box to designate the rule pursuant to which this Schedule is
filed:
[ ] Rule
13d-1(b)
[X] Rule
13d-1(c)
[ ] Rule
13d-1(d)
*The
remainder of this cover page shall be filled out for a reporting person’s
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The
information required in the remainder of this cover page shall not be deemed to
be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934
(“Act”) or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the
Notes).
Persons
who respond to the collection of information contained in this form are not
required to respond unless the form displays a currently valid OMD control
number.
SEC 1745
(3-06)
|
------------------------------------------------------
|
|
|
CUSIP
No. 09056N103
|
|
------------------------------------------------------
|
|
|
|
---------------------------------------------------------------------------------------------------------------------------------
|
|
1
|
Names
of Reporting Persons
|
|
|
I.R.S.
Identification Nos. of above persons (entities only)
|
|
|
|
|
Healthinvest
Partners AB
|
|
---------------------------------------------------------------------------------------------------------------------------------
|
|
2
|
Check
the Appropriate Box if a Member of a Group (See
Instructions)
|
|
|
|
|
(a) [ ]
|
|
|
(b) [X]
|
|
---------------------------------------------------------------------------------------------------------------------------------
|
|
3
|
SEC
Use Only
|
|
---------------------------------------------------------------------------------------------------------------------------------
|
|
4
|
Citizenship
or Place of Organization
|
|
|
|
|
Sweden
|
|
---------------------------------------------------------------------------------------------------------------------------------
|
|
|
|
Number
of
|
5
|
Sole Voting
Power
576,641
|
|
----------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
Shares
|
|
Beneficially
|
6
|
Shared Voting
Power
0
|
|
----------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
Owned
by
|
|
Each
|
7
|
Sole Dispositive
Power
576,641
|
|
----------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
Reporting
|
|
Person
With:
|
8
|
Shared Dispositive
Power
0
|
|
----------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
9
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
|
|
|
|
|
576,641
|
|
----------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
10
|
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions) [ ]
|
|
|
|
|
----------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
11
|
Percent
of Class Represented by Amount in Row (9)
|
|
|
|
|
4.0%
|
|
----------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
12
|
Type
of Reporting Person (See Instructions)
|
|
|
|
|
IA,
HC
|
|
----------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
|
|
------------------------------------------------------
|
|
|
CUSIP
No. 09056N103
|
|
------------------------------------------------------
|
|
|
|
---------------------------------------------------------------------------------------------------------------------------------
|
|
1
|
Names
of Reporting Persons
|
|
|
I.R.S.
Identification Nos. of above persons (entities only)
|
|
|
|
|
HealthInvest
Global Long/Short Fund
|
|
---------------------------------------------------------------------------------------------------------------------------------
|
|
2
|
Check
the Appropriate Box if a Member of a Group (See
Instructions)
|
|
|
|
|
(a) [ ]
|
|
|
(b) [
X ]
|
|
---------------------------------------------------------------------------------------------------------------------------------
|
|
3
|
SEC
Use Only
|
|
---------------------------------------------------------------------------------------------------------------------------------
|
|
4
|
Citizenship
or Place of Organization
|
|
|
|
|
Sweden
|
|
---------------------------------------------------------------------------------------------------------------------------------
|
|
|
|
Number
of
|
5
|
Sole Voting
Power
0
|
|
--------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
Shares
|
|
Beneficially
|
6
|
Shared Voting
Power
576,641
|
|
--------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
Owned
by
|
|
Each
|
7
|
Sole Dispositive
Power
0
|
|
--------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
Reporting
|
|
Person
With:
|
8
|
Shared Dispositive
Power
576,641
|
|
---------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
9
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
|
|
|
|
|
576,641
|
|
---------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
10
|
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions) [ ]
|
|
|
|
|
---------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
11
|
Percent
of Class Represented by Amount in Row (9)
|
|
|
|
|
4.0%
|
|
---------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
12
|
Type
of Reporting Person (See Instructions)
|
|
|
|
|
OO
|
|
---------------------------------------------------------------------------------------------------------------------------------------------------------
|
|
|
|
Item
1(a)
|
Name
of Issuer
|
|
|
Bio-Imaging
Technologies, Inc.
|
|
|
|
|
Item
1(b)
|
Address
of Issuer's Principal Executive Offices
|
|
|
826
Newtown-Yardley Road
|
|
|
Newtown,
Pennsylvania 18940-1721
|
|
|
|
|
Item
2(a)
|
Name
of Person Filing
|
|
|
Healthinvest
Partners AB and HeathInvest Global Long/Short Fund.
|
|
|
Healthinvest
Partners AB is the investment advisor and control person of HealthInvest
Global Long/Short Fund, a security holder of the
issuer. HealthInvest Global Long/Short Fund is a specialty fund
organized pursuant to the Swedish Mutual Funds Act.
|
|
|
|
|
Item
2(b)
|
Address
of Principal Business Office or, if none, Residence
|
|
|
Arsenalsgatan
4
|
|
SE-111
47 Stockholm
|
|
Sweden
|
|
|
|
Item
2(c)
|
Citizenship
|
|
|
See
the response(s) to Item 4 on the attached cover
page(s).
|
|
|
|
|
Item
2(d)
|
Title
of Class of Securities
|
|
|
Common
Stock
|
|
|
|
|
Item
2(e)
|
CUSIP
Number
|
|
|
09056N103
|
|
|
|
|
Item
3
|
If
this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c),
check whether the person filing is a:
|
|
|
Not
Applicable
|
|
Item
4
|
Ownership
|
|
|
|
|
(a)
|
Amount
Beneficially owned:
|
|
|
See
the response(s) to Item 9 on the attached cover
page(s).
|
|
|
|
|
(b)
|
Percent
of Class:
|
|
|
See
the response(s) to Item 11 on the attached cover page(s), which was
determined by dividing the number of shares beneficially held by the
Reporting Person by 14,252,425, the number of shares of common stock
issued and outstanding as reported in the Issuer’s Form 10-Q filed with
the Securities and Exchange Commission on May 13, 2008.
|
|
|
|
|
|
(c)
|
Number
of shares as to which the person has:
|
|
|
|
|
(i)
|
Sole
power to vote or to direct the vote:
|
|
|
|
See
the response(s) to Item 5 on the attached cover
page(s).
|
|
|
|
|
(ii)
|
Shared
power to vote or to direct the vote:
|
|
|
|
See
the response(s) to Item 6 on the attached cover
page(s).
|
|
|
|
|
(iii)
|
Sole
power to dispose or to direct the disposition of:
|
|
|
|
See
the response(s) to Item 7 on the attached cover
page(s).
|
|
|
|
|
(iv)
|
Shared
power to dispose or to direct the disposition of:
|
|
|
|
See
the response(s) to Item 8 on the attached cover
page(s).
|
|
|
|
Item
5
|
Ownership
of Five Percent or Less of a Class.
|
|
|
If
this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more
than five percent of the class of securities, check the
following [X].
|
|
|
|
Item
6
|
Ownership
of More Than Five Percent on Behalf of Another Person.
|
|
|
Not
Applicable.
|
|
|
|
Item
7
|
Identification
and Classification of the Subsidiary Which Acquired the Security Being
Reported on By the Parent Holding Company.
|
|
|
Not
Applicable.
|
|
|
|
Item
8
|
Identification
and Classification of Members of the Group.
|
|
|
Not
Applicable.
|
|
|
|
Item
9
|
Notice
of Dissolution of Group.
|
|
|
Not
Applicable.
|
|
|
|
Item
10
|
Certification.
|
|
|
By
signing below I certify that, to the best of my knowledge and belief, the
securities referred to above were not acquired and are not held for the
purpose of or with the effect of changing or influencing the control of
the issuer of the securities and were not acquired and are not held in
connection with or as a participant in any transaction having that purpose
or effect.
|
SIGNATURE
|
After
reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and
correct.
|
|
DATE:
|
June
19, 2008
|
|
|
|
HEALTHINVEST
PARTNERS AB
|
|
|
|
|
By:
/s/ ANDERS HALLBERG
|
|
|
|
|
|
Name:
Anders Hallberg
|
|
|
Title: Managing
Director and CEO
|
|
|
|
|
|
|
HEALTHINVEST
GLOBAL LONG/SHORT FUND
|
|
|
|
|
|
By:
/s/ ANDERS HALLBERG
|
|
|
|
|
|
Name: Anders
Hallberg
|
|
|
Title: CEO
of Managing Company
|
|
|
|
BIOTIE THERAPIES CORP. (NASDAQ:BITI)
Historical Stock Chart
From Oct 2024 to Nov 2024
BIOTIE THERAPIES CORP. (NASDAQ:BITI)
Historical Stock Chart
From Nov 2023 to Nov 2024
